BevCanna Advances to Final Stage of Health Canada Standard Processing Licence businesswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesswire.com Daily Mail and Mail on Sunday newspapers.
BevCanna Advances to Final Stage of Health Canada Standard Processing Licence VANCOUVER, British Columbia (Business Wire) Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) (“
BevCanna” or the “
Company”) is pleased to announce today that its application for a Standard Processing Licence has advanced to the final stages of the in depth review with Health Canada.
BevCanna and Health Canada are in closing discussions. The Company submitted its formal responses to Health Canada’s Request for More Information (RMI) on December 8, 2020, and has received confirmation from the Health Canada Assigned Reviewer that no additional RMIs are anticipated.
Share:
VANCOUVER, British Columbia, Dec. 16, 2020 (GLOBE NEWSWIRE)
Pure Extracts Technologies Corp. (CSE:PULL) (XFRA: A2QJAJ) ( Pure Extracts or the Company ), a plant-based extraction company, is pleased to announce that it has begun to build-out the 4
th unit in its facility for the extraction of mushrooms and to commence research and development of psilocybin under a Dealer s Licence.
The Company is preparing an application to Health Canada for a Dealer s Licence under the Controlled Drugs and Substances Act (CDSA), which provides, among other things, the framework for legal access to controlled substances, and the control and regulation of production, distribution and sale of psilocybin.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
REPEAT - Pure Extracts Applauds Health Canada SAP for Psilocybin-Assisted Psychotherapy Inclusion
Pure Extracts Technologies Corp.December 15, 2020 GMT Special Access Programme Review Considered a Milestone Event Toward Mainstream Acceptance
VANCOUVER, British Columbia, Dec. 15, 2020 (GLOBE NEWSWIRE) Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, and the rapidly emerging functional mushroom sector, is pleased to support Health Canada’s proposed intent to revise the Special Access Programme (SAP) and related regulations to permit certain authorized uses of psilocybin-assisted psychotherapeutic treatments. The intended SAP revision, announced on December 11th, could lead to important new medical applications, particularly in the complex and growing mental health secto
VANCOUVER, British Columbia, Dec. 14, 2020 (GLOBE NEWSWIRE)
Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, and the rapidly emerging functional mushroom sector, is pleased to support Health Canada’s proposed intent to revise the Special Access Programme (SAP) and related regulations to permit certain authorized uses of psilocybin-assisted psychotherapeutic treatments. The intended SAP revision, announced on December 11th, could lead to important new medical applications, particularly in the complex and growing mental health sector.
Health Canada’s announcement could act as a milestone achievement driving advanced research initiatives forward. This includes several ongoing clinical trials that consistently indicate breakthrough therapy potential of psilocybin-assisted psychotherapy for a number of mental health patients suffering from conditions where conventi